These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 36059542)
1. Involvement of He Z; Tian W; Wei Q; Xu J Front Immunol; 2022; 13():968649. PubMed ID: 36059542 [No Abstract] [Full Text] [Related]
2. Hussan H; Clinton SK; Roberts K; Bailey MT World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871 [TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population. Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057 [TBL] [Abstract][Full Text] [Related]
5. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study. Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118 [TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients. Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953 [TBL] [Abstract][Full Text] [Related]
7. Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer. Lee DW; Han SW; Kang JK; Bae JM; Kim HP; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY Ann Surg Oncol; 2018 Oct; 25(11):3389-3395. PubMed ID: 30062471 [TBL] [Abstract][Full Text] [Related]
8. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607 [TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553 [TBL] [Abstract][Full Text] [Related]
11. Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144 [TBL] [Abstract][Full Text] [Related]